1.
Kruger S, Boeck S, Heinemann V, Laubender RP, Vehling-Kaiser U, Waldschmidt D, et al. Impact of hand-foot skin reaction on treatment outcome in patients receiving capecitabine plus erlotinib for advanced pancreatic cancer: A subgroup analysis from AIO-PK0104. AO [Internet]. 2015 Aug. 9 [cited 2026 May 15];54(7):993-1000. Available from: https://medicaljournalssweden.se/actaoncologica/article/view/26294